secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2021-10-12T23:59:59+00:00
Accession:  0001077183-21-000225
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics appoints Lynn Tetrault as Non-Executive Chair; VanOort to retire from board
--------------------------------------------------------------------------------

- Douglas VanOort resigned as Executive Chairman and Chair of the Board effective Oct 7, 2021; plans to retire from board by year-end.
- Lynn Tetrault, former Lead Independent Director, appointed as Non-executive Chair effective Oct 7, 2021.
- Tetrault to receive additional quarterly fee of $15,625 and a $50,000 equity grant for her role as Chair.
- VanOort's resignation was not due to any dispute with the Company, management, or Board.
- Tetrault brings over 25 years of healthcare experience, including EVP at AstraZeneca.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718321000225/0001077183-21-000225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718321000225/neo-20211005.htm
  HTML page:      https://secwatch.observer/filing/0001077183-21-000225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer